Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: JB Williams

This article was originally published in The Tan Sheet

Executive Summary

JB Williams: Submits "belated" comments to FDA regarding the January 1988 tentative final monograph for OTC oral health care products on April 18. The company, which sells Cepacol Maximum Strength Sore Throat Spray, is requesting that the agency "amend the directions for dosage forms" to allow "continued use of directions similar to or the same as those already in use for marketed OTC anesthetic/analgesic sprays." Directions for use in the TFM would instruct consumers to "gargle, swish around or allow to remain in place for at least one minute and then spit out" a liquid anesthetic/analgesic, which the company points out is inappropriate for sprays...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts